AstraZeneca and the University of Oxford are pausing the study of the corona vaccine because a potentially serious side effect has occurred in one of the British subjects. This is evident from a statement that AstraZeneca to several media, including STAT News, AP en CNN, has sent. Brazil, one of the countries where AstraZeneca is currently testing the vaccine, confirms the break.
It is not known what the particular side effect would be and when it happened. The patient may have become ill, but this is not due to the vaccine. AstraZeneca says they have voluntarily paused the test so that the affected participant can be examined.
The pause would be routine and part of the procedure for when an unexpected illness occurs in a medical test, AstraZeneca reports in a statement sent to multiple international media outlets.
The investigation into the side effect must be completed as soon as possible, so that the investigation can be completed on time as planned. It is still unclear how long this break will last.
The first test results of the vaccine were published in the journal in July The Lancet and were positive. Some side effects were seen, but these were not serious.
EU hopes for 30 million doses of vaccine by the end of this year
The vaccine from AstraZeneca and Oxford University called AZD1222. The European Union reported last week that it is hoped for 30 million doses for EU member states by the end of this year. The European Commission signed a deal with AstraZeneca for 300 million doses, worth EUR 336 million.
The first test results were published in July. “It is safe and triggers a response from the immune system,” the researchers said.
– .
